loadpatents
Patent applications and USPTO patent grants for Arntzen; Charles.The latest application filed is for "geminiviral vector for expression of rituximab".
Patent | Date |
---|---|
Geminiviral Vector For Expression Of Rituximab App 20190194680 - Mason; Hugh ;   et al. | 2019-06-27 |
Geminiviral vector for expression of rituximab Grant 10,125,373 - Mason , et al. November 13, 2 | 2018-11-13 |
Synbodies for detection of human norovirus Grant 9,766,239 - Gupta , et al. September 19, 2 | 2017-09-19 |
Synbodies for Detection of Human Norovirus App 20160153991 - GUPTA; Nidhi ;   et al. | 2016-06-02 |
Geminiviral Vector For Expression Of Rituximab App 20150368660 - Mason; Hugh ;   et al. | 2015-12-24 |
Methods and compositions for stable transgenic plant pharmaceuticals and their use as contraceptives App 20040175440 - Kirk, Dwayne ;   et al. | 2004-09-09 |
Gemini virus vectors for gene expression in plants App 20030079248 - Mason, Hugh ;   et al. | 2003-04-24 |
Gemini virus vectors for gene expression in plants Grant 6,392,121 - Mason , et al. May 21, 2 | 2002-05-21 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.